Consort Medical plc (LON:CSRT) has been assigned a consensus rating of “Buy” from the seven ratings firms that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is GBX 1,153.17 ($15.02).

Several equities analysts have issued reports on the company. Stifel Nicolaus reissued a “hold” rating and issued a GBX 1,100 ($14.32) price target on shares of Consort Medical plc in a research note on Thursday, June 15th. Shore Capital reissued a “buy” rating on shares of Consort Medical plc in a research note on Thursday, June 15th. Panmure Gordon reissued a “buy” rating and issued a GBX 1,145 ($14.91) price target on shares of Consort Medical plc in a research note on Thursday, June 15th. N+1 Singer reissued a “buy” rating and issued a GBX 1,125 ($14.65) price target on shares of Consort Medical plc in a research note on Thursday, June 15th. Finally, Numis Securities Ltd reissued a “hold” rating and issued a GBX 1,084 ($14.12) price target on shares of Consort Medical plc in a research note on Thursday, June 15th.

In other news, insider Paul Hayes bought 4,000 shares of the stock in a transaction dated Tuesday, June 20th. The shares were bought at an average cost of GBX 1,094 ($14.25) per share, with a total value of £43,760 ($56,986.59).

Consort Medical plc (CSRT) traded down 0.36% during mid-day trading on Tuesday, reaching GBX 1096.00. The company had a trading volume of 2,272 shares. Consort Medical plc has a one year low of GBX 960.00 and a one year high of GBX 1,180.00. The firm’s market capitalization is GBX 536.09 million. The firm’s 50-day moving average is GBX 1,055.00 and its 200-day moving average is GBX 1,033.57.

The company also recently announced a dividend, which will be paid on Friday, October 27th. Stockholders of record on Thursday, September 21st will be given a dividend of GBX 13.21 ($0.17) per share. This represents a dividend yield of 1.3%. This is a positive change from Consort Medical plc’s previous dividend of $7.09. The ex-dividend date is Thursday, September 21st.

TRADEMARK VIOLATION WARNING: “Consort Medical plc (CSRT) Given Consensus Rating of “Buy” by Brokerages” was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/08/08/consort-medical-plc-csrt-given-consensus-rating-of-buy-by-brokerages.html.

About Consort Medical plc

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.

Analyst Recommendations for Consort Medical plc (LON:CSRT)

Receive News & Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related companies with MarketBeat.com's FREE daily email newsletter.